系统性硬化症EUSTAR队列中三尖瓣环收缩期位移与收缩期肺动脉压比值与2型心肾综合征的关联
基于EUSTAR队列2370例系统性硬化症患者,评估三尖瓣环收缩期位移/收缩期肺动脉压比值(TAPSE/sPAP)与估算肾小球滤过率(eGFR)及死亡率的关联。TAPSE/sPAP降低与慢性肾脏病(CKD)3a-5期独立相关,TAPSE/sPAP≤0.32 mm/mm Hg和eGFR<60 mL/min/1.73 m2是全因死亡的预后因素。在右心导管确诊肺动脉高压的患者中,eGFR与心输出量降低无关。
要点
- TAPSE/sPAP与CKD 3a-5期独立相关(OR 0.479)。
- TAPSE/sPAP≤0.32 mm/mm Hg是全因死亡预后因素(HR 3.589)。
- eGFR<60 mL/min/1.73 m2是全因死亡预后因素(HR 2.818)。
核心结论
- TAPSE/sPAP比值降低与CKD独立相关。
- TAPSE/sPAP≤0.32 mm/mm Hg和eGFR<60 mL/min/1.73 m2是全因死亡的预后因素。
- 在系统性硬化症合并肺动脉高压患者中,eGFR与心输出量降低无关。
研究设计与样本
- 纳入EUSTAR数据库中具有TAPSE、sPAP及计算eGFR所需参数的系统性硬化症患者。
- 采用逻辑回归和Cox回归分析评估TAPSE/sPAP作为CKD和总生存的风险因素。
- 共纳入2370例系统性硬化症患者,其中284例(12%)为CKD 3a-5期。
主要发现
- TAPSE/sPAP(OR 0.479;95%CI 0.310-0.743;P<0.001)、动脉性高血压(OR 3.118;95%CI 2.173-4.475;P<0.001)、舒张功能障碍(OR 1.670;95%CI 1.148-2.428;P<0.01)和N末端B型利钠肽原(OR 1.165;95%CI 1.041-1.304;P<0.01)与CKD 3a-5期相关。
- TAPSE/sPAP≤0.32 mm/mm Hg(HR 3.589;95%CI 2.236-5.761;P<0.001)、eGFR<60 mL/min/1.73 m2(HR 2.818;95%CI 1.777-4.468;P<0.001)和年龄(HR 1.782;95%CI 1.348-2.356;P<0.001)是全因死亡的最显著预测因素。
- 276例经右心导管确诊肺动脉高压的系统性硬化症患者中,69例(25%)为CKD 3a-5期;心指数降低与心指数正常的肺动脉高压患者之间eGFR无差异。
关键数值与推荐
- TAPSE/sPAP≤0.32 mm/mm Hg对应全因死亡HR 3.589(95%CI 2.236-5.761;P<0.001)。
- eGFR<60 mL/min/1.73 m2对应全因死亡HR 2.818(95%CI 1.777-4.468;P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the study was to evaluate the association between the tricuspid annular plane systolic excursion (TAPSE)/systolic pulmonary artery pressure (sPAP) ratio and estimated glomerular filtration rate (eGFR) and their association with mortality in the European Scleroderma Trials and Research (EUSTAR) cohort. METHODS: Patients with systemic sclerosis (SSc) from the EUSTAR database with TAPSE, sPAP, and parameters required to calculate eGFR were included. Logistic regression and Cox regression analysis were performed to evaluate TAPSE/sPAP as a risk factor for chronic kidney disease (CKD) and overall survival. RESULTS: A total of 2,370 patients with SSc were included; 284 (12%) patients had CKD stage 3a-5. TAPSE/sPAP (odds ratio [OR] 0.479; 95% CI 0.310-0.743; P < 0.001), arterial hypertension (OR 3.118; 95% CI 2.173-4.475; P < 0.001), diastolic dysfunction (OR 1.670; 95% CI 1.148-2.428; P < 0.01), and N-terminal pro-B-type natriuretic peptide (OR 1.165; 95% CI 1.041-1.304; P < 0.01) were associated with CKD stage 3a-5. TAPSE/sPAP ≤0.32 mm/mm Hg (hazard ratio [HR] 3.589; 95% CI 2.236-5.761; P < 0.001), eGFR <60 mL/min per 1.73 m2 (HR 2.818; 95% CI 1.777-4.468; P < 0.001), and age (HR 1.782; 95% CI 1.348-2.356; P < 0.001) were the most significant predictive factors for all-cause mortality. A total of 276 patients with SSc had pulmonary hypertension (PH) confirmed by right-sided heart catheterization, with 69 (25%) having CKD stage 3a-5. No difference was found in eGFR between patients with PH with reduced or normal cardiac index. CONCLUSION: Reduced TAPSE/sPAP ratio is independently associated with CKD. TAPSE/sPAP ratio ≤0.32 mm/mm Hg and eGFR <60 mL/min per 1.73 m2 are prognostic factors for all-cause mortality. In patients with SSc with PH, eGFR is independent by reduced cardiac output.
引用
- Colalillo A, Pellicano C, Ananyeva LP, et al. Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care Res (Hoboken). 2023. PMID: 37458105. doi:10.1002/acr.25196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。